HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients - Canini, Laetitia; Imamura, Michio; Kawakami, Yoshiiku; Uprichard, Susan L.; Cotler, Scott J.; Dahari, Harel; Chayama, Kazuaki (PloS one, 2017)
Keywords: Antiviral Agents - administration & dosage; Antiviral Agents - therapeutic use; Biology and life sciences; Complications and side effects; Daclatasvir; Dosage and administration; Drug therapy; Hepacivirus - physiology; Hepatitis C; Hepatitis C, Chronic - drug therapy; Humans; Imidazoles - administration & dosage; Imidazoles - therapeutic use; Isoquinolines - administration & dosage; Isoquinolines - therapeutic use; Kinetics; Life Sciences; Medicine and health sciences; Research and Analysis Methods; Sulfonamides - administration & dosage; Sulfonamides - therapeutic use; United States; United Kingdom